Summary
This research article explores how Swiss biotech companies are pivotal in the global pharmaceutical landscape, contributing significantly to R&D and commercialization. It highlights Switzerland's unique ecosystem, clinical trial leadership, and the success of local firms in launching innovative therapies. The article is part of the Swiss Biotech Report 2023, showcasing the growth and investment trends in the sector.
